汇宇制药：产品获得境外上市许可

Core Viewpoint - Seacross Pharma (Europe) Ltd. and Seacross Pharmaceuticals Ltd., subsidiaries of the company, have received marketing approvals for their products, injectable Parecoxib Sodium and injectable Pemetrexed Disodium, from the Dutch Medicines and Medical Devices Authority and the Saudi Food and Drug Authority respectively [1] Summary by Categories - Regulatory Approvals - The company’s subsidiaries have obtained marketing licenses for injectable Parecoxib Sodium and injectable Pemetrexed Disodium [1] - Approvals were granted by the Dutch Medicines and Medical Devices Authority and the Saudi Food and Drug Authority [1]